Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

China · Delayed Price · Currency is CNY

5.05

+0.17 (3.48%)

Jun 29, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
in Vitro Diagnostic Reagents, Supporting Instruments and Consumables	549.60M		-	-	-	-
Medical Testing Services	267.26M		-	-	-	-
Medical Services	27.49M		-	-	-	-
Offset of Business Segment	-174.71M		-	-	-	-
Total	669.64M		-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	641.11M		1.03B	3.93B	1.86B	1.17B
China Growth	-		-73.76%	110.84%	58.73%	67.18%
Overseas	28.53M		73.12M	1.67B	808.78M	180.05M
Overseas Growth	-		-95.61%	106.03%	349.20%	569.57%
Total	669.64M		1.10B	5.60B	2.67B	1.35B
Total Growth	-		-80.27%	109.39%	97.34%	85.70%